Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Biophytis to meet with FDA to advance Sarconeos (BIO101) development in Sarcopenia from Phase 2 to Phase 3
Biophytis to meet with FDA to advance Sarconeos (BIO101) development in Sarcopenia from Phase 2 to Phase 3
Biophytis to meet with FDA to advance Sarconeos (BIO101) development in Sarcopenia from Phase 2 to Phase 3
Samarkand Group plc : Interim Results
Samarkand Group plc : Interim Results
Samarkand Group plc : Interim Results
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
DGAP-News: VIB Vermögen AG: Joint Venture VIB/WDP rents out 46.000 sqm in Gelsenkirchen
DGAP-News: VIB Vermögen AG: Joint Venture VIB/WDP rents out 46.000 sqm in Gelsenkirchen
DGAP-News: VIB Vermögen AG: Joint Venture VIB/WDP rents out 46.000 sqm in Gelsenkirchen
DGAP-News: APONTIS PHARMA strengthens management for future growth: Thomas Zimmermann appointed new CFO
DGAP-News: APONTIS PHARMA strengthens management for future growth: Thomas Zimmermann appointed new CFO
DGAP-News: APONTIS PHARMA strengthens management for future growth: Thomas Zimmermann appointed new CFO
DGAP-News: Deutsche Konsum REIT-AG with successful completion of the 2020/2021 financial year
DGAP-News: Deutsche Konsum REIT-AG with successful completion of the 2020/2021 financial year
DGAP-News: Deutsche Konsum REIT-AG with successful completion of the 2020/2021 financial year
EQS-News: Straumann Group presents evolved strategy to achieve its long-term revenue ambition of CHF 5 billion
EQS-News: Straumann Group presents evolved strategy to achieve its long-term revenue ambition of CHF 5 billion
EQS-News: Straumann Group presents evolved strategy to achieve its long-term revenue ambition of CHF 5 billion
EQS-Adhoc: Relief Therapeutics Files Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
EQS-Adhoc: Relief Therapeutics Files Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
EQS-Adhoc: Relief Therapeutics Files Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
DGAP-News: SHOP APOTHEKE EUROPE Launches its Own Marketplace.
DGAP-News: SHOP APOTHEKE EUROPE Launches its Own Marketplace.
DGAP-News: SHOP APOTHEKE EUROPE Launches its Own Marketplace.
EQS-Adhoc: Swiss Prime Site acquires Zug-based Akara Group
EQS-Adhoc: Swiss Prime Site acquires Zug-based Akara Group
EQS-Adhoc: Swiss Prime Site acquires Zug-based Akara Group
Form 8 (DD) - Paul Zwillenberg  PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT
Form 8 (DD) - Paul Zwillenberg PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT
Form 8 (DD) - Paul Zwillenberg PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT
DGAP-News: Abivax to present at the J.P. Morgan 40th Annual Healthcare Conference
DGAP-News: Abivax to present at the J.P. Morgan 40th Annual Healthcare Conference
DGAP-News: Abivax to present at the J.P. Morgan 40th Annual Healthcare Conference
DGAP-News: Vita 34 presents itself in new size for the first time at the Annual General Meeting 2021
DGAP-News: Vita 34 presents itself in new size for the first time at the Annual General Meeting 2021
DGAP-News: Vita 34 presents itself in new size for the first time at the Annual General Meeting 2021
Rights and Issues Investment Trust PLC: Transaction in Own Shares
Rights and Issues Investment Trust PLC: Transaction in Own Shares
Rights and Issues Investment Trust PLC: Transaction in Own Shares
Lyxor International Asset Management: Lyxor ETF - NAV publication issue for LSE listed ETFs
Lyxor International Asset Management: Lyxor ETF - NAV publication issue for LSE listed ETFs
Lyxor International Asset Management: Lyxor ETF - NAV publication issue for LSE listed ETFs
EQS-News: Sensirion Holding AG: VOC+NOx sensor for indoor air quality applications is now available worldwide
EQS-News: Sensirion Holding AG: VOC+NOx sensor for indoor air quality applications is now available worldwide
EQS-News: Sensirion Holding AG: VOC+NOx sensor for indoor air quality applications is now available worldwide
DGAP-News: FYI Resources: OUTSTANDING RESULTS FROM JOINT HPA TRIAL
DGAP-News: FYI Resources: OUTSTANDING RESULTS FROM JOINT HPA TRIAL
DGAP-News: FYI Resources: OUTSTANDING RESULTS FROM JOINT HPA TRIAL
DGAP-News: Mynaric receives 2021 Pioneer Space Business Award of the Year from Euroconsult
DGAP-News: Mynaric receives 2021 Pioneer Space Business Award of the Year from Euroconsult
DGAP-News: Mynaric receives 2021 Pioneer Space Business Award of the Year from Euroconsult
HMS Group Reports Rub 5.2 billion EBITDA for 9 months 2021
HMS Group Reports Rub 5.2 billion EBITDA for 9 months 2021
HMS Group Reports Rub 5.2 billion EBITDA for 9 months 2021
Form 8.3 - Maitland Institutional Services Limited: Form 8.3 (OPD) - Tungsten Corp Plc
Form 8.3 - Maitland Institutional Services Limited: Form 8.3 (OPD) - Tungsten Corp Plc
Form 8.3 - Maitland Institutional Services Limited: Form 8.3 (OPD) - Tungsten Corp Plc
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Playtech plc
Form 8.3 - The Vanguard Group, Inc.: Playtech plc
Form 8.3 - The Vanguard Group, Inc.: Playtech plc